definiens: ) . Company shall, within the time defined in the Clinical Quality Agr eement, perform, with respect to the [COMPANY] Compound, the acceptance ( including testing ) procedures allocated to it under the Clinical Quality Agreement . Compan y shall be solely responsible for taking all steps necessary t o determine that [COMPANY] Compound or Company Compound, as applicable, is suitable for release before making s uch [COMPANY] Compound or Company Compound, as applicab le, available for human use, and [COMPANY] shall provide co operation or assistance as reasonably requested by Company in connection with such determination with respect to the [COMPANY] Compound . Company shall be responsible for storage and maintenance of the [COMPANY] Compound until it is tested and/or released, which storage and ma intenance shall be in compliance with ( a ) the Specifications for the [COMPANY] Compound, the Clinical Quality Agreem ent and Applicable Law and ( b ) any specific storage and mai ntenance requirements as may be provided by [COMPANY] f rom time to time . Company shall be responsible for any failure of the [COMPANY] Compound to meet the Specifica tions to the extent caused by shipping, storage or handling conditions after Delivery to Company hereunder